"Expanding knowledge and access
to emergency contraception"
"Expanding knowledge and access to emergency contraception in Europe"
June 2024. A recent study assessed the availability of emergency contraceptive pills (ECPs) in Australian community pharmacies. The study found that 30 % of the pharmacies surveyed did not stock ulipristal acetate (UPA) ECPs, despite being recommended as the first-line oral EC. On average, UPA ECPs were 13$ more expensive than LNG ECPs. ECP accessibility…
May 2024. Two recent studies looked into EC dispensing practices in community pharmacies in Europe.
May 2024. In Poland on May 1st, 2024, a new regulation came into effect as a temporary pilot program, through which individuals over the age of 15 can consult with a pharmacist, obtain a prescription, and directly purchase UPA ECP. To date, a visit to a doctor was needed to obtain a prescription, prior to…
May 2024. Switzerland and the United Kingdom are the only two European countries where pharmacists are mandated to counsel individuals seeking emergency contraception. A recent study by the Pharmaceutical Care Research Group of the University of Basel, looked at customer satisfaction with the counselling received in 195 Swiss pharmacies. Results show that the need for…
April 2024. In 2022 the World Health Organization (WHO) included the recommendation of “making emergency contraception pills available without prescription”, in its Guideline on Self-care interventions for health and well-being. The recommendation was based on a systematic review conducted in 2021. Now WHO publishes a technical document to further disseminate this recommendation and the evidence behind it. A…
April 2024. DKT International recently published a paper sharing the results of it social marketing strategy to expand the EC market in Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Guinea, Mali, Niger, Senegal, Togo. DKT focused on offering high-quality, affordable EC, while carrying out “high-visibility, positive campaigns to end-users and raising awareness with pharmacists and healthcare…
April 2024. We are thrilled to announce that the International Pharmaceutical Federation (FIP) has endorsed the consensus statement published last September by the European Society of Contraception and Reproductive Health (ESC), the International Federation of Gynecology and Obstetrics (FIGO), the International Planned Parenthood Federation (IPPF), and the European Consortium for Emergency Contraception. The consensus statement recommends…
April 2024. According to the Russian State Register of Medical Products emergency contraception (EC) pills containing levonorgestrel under the brand names Escapel and Postinor, have been switched to OTC products and can be bought without a doctor’s prescription since January 2024. See registration certificates here and here.
April 2024. On March 29, Polish President Andrzej Duda refused to sign the amendment to the Pharmaceutical Law that proposed making emergency contraception pills (ECPs) available without a prescription for individuals above 15 years old (read here). In efforts to find alternative ways to make ECPs more accessible, on April 3rd, the Ministry of…
March 2024. In January 2019 a pharmacist refused to fill a prescription for the ulipristal acetate emergency contraception pill (ECP), in Aitkin County (a rural area of Minnesota) citing his religious believes. The case was brought to the county court in August 2022, where the jury found that the pharmacist had not discriminated against the…
March 2024. The Center for Reproductive Rights (CRR) and partners launched Pathways to Change, a joint publication presenting the stories and strategies that have advanced sexual and reproductive health and rights (SRHR) in a number of countries around the world. The book includes a vivid explanation and analysis of the strategy led by the Women’s…
February 2024. On February 22, the Polish Parliament voted to approved access to emergency contraception pills without a prescription for individuals aged 15 and over. Following the approval by the Parliament, the bill will proceed to the Senate for further consideration. Upon approval by the Senate, the bill will then require the President’s signature to…
Menú
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy
